Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus.
about
A commensal Helicobacter sp. of the rodent intestinal flora activates TLR2 and NOD1 responses in epithelial cellsThe complete genome sequence of the carcinogenic bacterium Helicobacter hepaticusDetection of Helicobacter hepaticus in human bile samples of patients with biliary diseaseHelicobacter bilis-induced inflammatory bowel disease in scid mice with defined floraCD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanismsRole of regulatory T cell in the pathogenesis of inflammatory bowel diseaseManipulating the Gut Microbiota: Methods and ChallengesThe Altered Schaedler Flora: Continued Applications of a Defined Murine Microbial CommunityPathobionts of the gastrointestinal microbiota and inflammatory diseaseCentral role of gimap5 in maintaining peripheral tolerance and T cell homeostasis in the gutThe microbiota and inflammatory bowel disease: insights from animal modelsIntestinal microbiota composition of interleukin-10 deficient C57BL/6J mice and susceptibility to Helicobacter hepaticus-induced colitisThe gut microbiota shapes intestinal immune responses during health and diseaseInflammatory bowel diseaseHelicobacter aurati sp. nov., a urease-positive Helicobacter species cultured from gastrointestinal tissues of Syrian hamsters.Helicobacter typhlonius sp. nov., a Novel Murine Urease-Negative Helicobacter Species.Cloning and expression of an immunogenic membrane-associated protein of Helicobacter hepaticus for use in an enzyme-linked immunosorbent assay.Comparative genomics and proteomics of Helicobacter mustelae, an ulcerogenic and carcinogenic gastric pathogen.The effect of Helicobacter hepaticus infection on immune responses specific to herpes simplex virus type 1 and characteristics of dendritic cells.Development of a PCR-restriction fragment length polymorphism assay using the nucleotide sequence of the Helicobacter hepaticus urease structural genes ureABSpatial distribution and stability of the eight microbial species of the altered schaedler flora in the mouse gastrointestinal tractRole of the microbiota in immunity and inflammation.Chronic active hepatitis induced by Helicobacter hepaticus in the A/JCr mouse is associated with a Th1 cell-mediated immune response.Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanismSCID/NCr mice naturally infected with Helicobacter hepaticus develop progressive hepatitis, proliferative typhlitis, and colitis.Pathogenic properties of enterohepatic Helicobacter spp. isolated from rhesus macaques with intestinal adenocarcinomaCytolethal distending toxin is essential for Helicobacter hepaticus colonization in outbred Swiss Webster mice.Enterohepatic helicobacter in ulcerative colitis: potential pathogenic entities?Isolation of Helicobacter canis from a colony of bengal cats with endemic diarrheaFluorogenic PCR-based quantitative detection of a murine pathogen, Helicobacter hepaticusEmergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases.Phylogeny of the defined murine microbiota: altered Schaedler flora.A novel urease-negative Helicobacter species associated with colitis and typhlitis in IL-10-deficient mice.Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease.Cytolethal distending toxin sequence and activity in the enterohepatic pathogen Helicobacter hepaticusColitis-induced bone loss is gender dependent and associated with increased inflammationMultidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?Association between Helicobacter spp. infections and hepatobiliary malignancies: a review.Long-term treatment of NZB mice with anti-CD4 results in wasting disease, lymphoid atrophy and chronic diarrhea.In vivo Treg suppression assays.
P2860
Q21143791-8867C581-E312-499C-A2E7-0BBC043D209CQ22066259-97FA6180-B51B-4E7A-8084-E0B971537E58Q24653842-37CCA67F-C8D5-4EED-8400-21DB2EF0A995Q24672956-EB4A26C8-929F-45FA-849B-D784E48C4A1CQ24673863-0C58C505-67C5-4B07-83EA-F1F390C36D04Q26768560-E05CD43F-684E-4EA2-99B2-661850F1AA4CQ26795704-E09F6400-9FB9-417B-BDCF-1782044D17FCQ26795708-D25B385A-7246-410C-BD63-6BD3A2A08403Q27008113-036C0039-D408-40C0-9CAF-94536560D4FDQ27025911-0AB578EF-1384-43F0-AC53-60943D965E91Q27027929-2A4BDC02-BA66-42AB-BAEC-F6FCB96A06B2Q27310097-13485E5A-E9FA-470C-AD51-219CEE60DC7CQ29547727-CF13E01E-0204-43C9-8980-0272C5F44D57Q29615500-801F812C-D206-4CAF-BDAC-1B4BCC9932ADQ30615349-F253CCEB-4CCF-4776-8604-A60558163A4CQ30664591-55D1060A-B7DA-419A-BC38-98A474864E7AQ30765308-1C051625-ABF7-4A95-8736-C3C6E648112CQ33539447-0D6AEDCF-18A2-4BB0-A936-2E2F0CCF8F09Q33560319-365D5947-5018-4671-8924-80BAEF978658Q33681216-8E946A2D-0037-44EF-8239-9F8DE9A4C879Q33707348-C8B665BC-2DB7-410A-8128-646B73EF789CQ33752553-816A83B9-4A62-469B-922D-2C86BF1519F7Q33756172-A2F69D7B-B42F-4BE9-89A7-F382CDE4027AQ33767365-5EB5BE6F-BC8E-4AD2-A0FD-F74BB95C1309Q33767950-78A42885-CC75-4F32-8432-D17F2D294A64Q33781233-9ADB2FFC-406A-4F00-A0A2-E86537F2A686Q33788269-EDB1269C-12B4-4311-9484-C388C835D11AQ33839318-26C23CCD-6351-4697-AD66-A61BDA3AE80DQ33962994-58118320-A281-4A86-A8F9-80ED9C75477DQ33972933-0C6FDF01-C97A-450A-8057-70602EF3E447Q33975615-CB54C5D2-51C0-472F-AC26-BBFDE1F2E859Q33985533-032BCE7F-8EE8-43D8-ACAE-2728270A04D9Q34000860-A695D876-D93A-4AD5-AF13-380DC23EDFFDQ34002778-38D6CE06-6F55-42E4-9F4F-99B2BB3A3462Q34003015-7AD57849-73E8-48AD-B2EC-54E1870CFF47Q34024554-88A94D16-AD8B-49FF-A991-8D9613E4C756Q34190195-F9B44352-F1BA-42F2-91DD-94FFAD393F16Q34461850-14A8BE93-CCAD-4EAC-9C62-ABBB8BDA1A15Q34503669-42A72A66-D1D6-41DC-AC59-1F04DAD8E57AQ34629722-558C89C5-7D8F-42AA-ADBF-542E5029D5A8
P2860
Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus.
description
1997 nî lūn-bûn
@nan
1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Inflammatory bowel disease: an ...... n with Helicobacter hepaticus.
@ast
Inflammatory bowel disease: an ...... n with Helicobacter hepaticus.
@en
type
label
Inflammatory bowel disease: an ...... n with Helicobacter hepaticus.
@ast
Inflammatory bowel disease: an ...... n with Helicobacter hepaticus.
@en
prefLabel
Inflammatory bowel disease: an ...... n with Helicobacter hepaticus.
@ast
Inflammatory bowel disease: an ...... n with Helicobacter hepaticus.
@en
P2093
P2860
P1476
Inflammatory bowel disease: an ...... on with Helicobacter hepaticus
@en
P2093
P2860
P304
P407
P577
1997-08-01T00:00:00Z